ORGN - NASDAQ
Origin Materials, Inc.
$0.34
+1.7%Micromidas, Inc., doing business as Origin Materials, produces and commercializes plant-based PET plastic. It develops a platform for turning the carbon found in biomass into useful materials, while capturing carbon in the process. The company serves tire filler, carbon black, agriculture, and activated carbon markets. Micromidas, Inc. has a strategic alliance with Palantir Technologies Inc. The company was incorporated in 2008 and is based in West Sacramento, California with a facility in Sarnia, Canada.
At a Glance
Live SnapshotOrigin Materials, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Cash Flow Quality Insight
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
Origin Materials, Inc. Cash Flow Statement
ORGN • NASDAQ
| Origin Materials, Inc. Cash Flow Statement | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||
-83.7M | 23.8M | 78.6M | 42.1M | -30.3M | -479.4K | |
10.7M | 3.4M | 1.3M | 824K | 479K | 645.8K | |
640K | -1.2M | 0.0 | 0.0 | 0.0 | 383.9K | |
10.1M | 9.4M | 0.0 | 5.8M | 1.6M | 43.8K | |
22M | -67.2M | -99.7M | -67.7M | 19.8M | -10M | |
(23K) | (129K) | (0.0) | (0.0) | (0.0) | (0.0) | |
-10.6M | -28.4M | -6.2M | -3M | 3M | 2.5M | |
-50.8M | -60.4M | -26.1M | -22M | -5.5M | -7.3M | |
INVESTING ACTIVITIES | ||||||
-9M | -102.2M | -83.7M | -12.3M | -1.8M | -7.1M | |
-1.8B | -3.6B | -3.8B | -2.4B | (0.0) | (0.0) | |
1.9B | 3.8B | 4B | 2B | 0.0 | 0.0 | |
0.0 | -7.9M | -245K | -201K | -268K | 0.0 | |
(28.6M) | (26.2M) | (88.8M) | -411.6M | -2.1M | -7.1M | |
FINANCING ACTIVITIES | ||||||
0.0 | 0.0 | 399K | 74K | 1K | 0.0 | |
-4.8M | 0.0 | 0.0 | 10.8M | 3.2M | 879.6K | |
8.3M | 146K | 849K | 468.1M | 2.7M | 3.5M | |
3.6M | 146K | 1.2M | 478.9M | 5.8M | 4.4M | |
CASH FLOW SUMMARY | ||||||
-480K | 1.1M | -2.8M | -14K | -52K | 425.2K | |
-19.2M | -32.8M | 61.2M | 45.3M | -1.7M | -9.6M | |
75.5M | 108.3M | 47.1M | 1.9M | 3.6M | 13.2M | |
56.3M | 75.5M | 108.3M | 47.1M | 1.9M | 3.6M | |
-59.8M | -170.5M | -109.8M | -34.5M | -7.5M | -14.5M |
SEC Filings
ORGN - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2025 N/A | December 11, 2025 | December 11, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 09, 2025 | November 25, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 17, 2025 | November 13, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 13, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 13, 2025 | November 13, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 08, 2025 | October 07, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 07, 2025 | October 07, 2025 | 2025 | |
S-3 S-3 N/A | August 14, 2025 | August 14, 2025 | ||
10-Q 10-Q 2025 Q2 Q2 | August 14, 2025 | June 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | August 14, 2025 | August 14, 2025 | 2025 |
Related Guides
Continue your ORGN research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.